Global Neurovascular Devices Market Overview:
Global Neurovascular Devices Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Neurovascular Devices Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Neurovascular Devices involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Neurovascular Devices Market:
The Neurovascular Devices Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Neurovascular Devices Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Neurovascular Devices Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Neurovascular Devices market has been segmented into:
Aneurysm Coiling & Embolization Devices
Cerebral Balloon Angioplasty and Stenting Systems
Support Devices
Neurothrombectomy Devices
and Others
By Application, Neurovascular Devices market has been segmented into:
Ischemic Strokes
Cerebral Aneurysms
Arteriovenous Malformation
and Fistulas and Other target diseases
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Neurovascular Devices market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Neurovascular Devices market.
Top Key Players Covered in Neurovascular Devices market are:
Medtronic
Johnson & Johnson
Stryker
Terumo Corporation
ASAHI INTECC CO.
LTD.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Neurovascular Devices Market Type
4.1 Neurovascular Devices Market Snapshot and Growth Engine
4.2 Neurovascular Devices Market Overview
4.3 Aneurysm Coiling & Embolization Devices
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Aneurysm Coiling & Embolization Devices: Geographic Segmentation Analysis
4.4 Cerebral Balloon Angioplasty and Stenting Systems
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Cerebral Balloon Angioplasty and Stenting Systems: Geographic Segmentation Analysis
4.5 Support Devices
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Support Devices: Geographic Segmentation Analysis
4.6 Neurothrombectomy Devices
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Neurothrombectomy Devices: Geographic Segmentation Analysis
4.7 and Others
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.7.3 and Others: Geographic Segmentation Analysis
Chapter 5: Neurovascular Devices Market Application
5.1 Neurovascular Devices Market Snapshot and Growth Engine
5.2 Neurovascular Devices Market Overview
5.3 Ischemic Strokes
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Ischemic Strokes: Geographic Segmentation Analysis
5.4 Cerebral Aneurysms
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Cerebral Aneurysms: Geographic Segmentation Analysis
5.5 Arteriovenous Malformation
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Arteriovenous Malformation: Geographic Segmentation Analysis
5.6 and Fistulas and Other target diseases
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 and Fistulas and Other target diseases: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Neurovascular Devices Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MEDTRONIC
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 JOHNSON & JOHNSON
6.4 STRYKER
6.5 TERUMO CORPORATION
6.6 ASAHI INTECC CO.
6.7 LTD.
Chapter 7: Global Neurovascular Devices Market By Region
7.1 Overview
7.2. North America Neurovascular Devices Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Aneurysm Coiling & Embolization Devices
7.2.2.2 Cerebral Balloon Angioplasty and Stenting Systems
7.2.2.3 Support Devices
7.2.2.4 Neurothrombectomy Devices
7.2.2.5 and Others
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Ischemic Strokes
7.2.3.2 Cerebral Aneurysms
7.2.3.3 Arteriovenous Malformation
7.2.3.4 and Fistulas and Other target diseases
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Neurovascular Devices Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Aneurysm Coiling & Embolization Devices
7.3.2.2 Cerebral Balloon Angioplasty and Stenting Systems
7.3.2.3 Support Devices
7.3.2.4 Neurothrombectomy Devices
7.3.2.5 and Others
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Ischemic Strokes
7.3.3.2 Cerebral Aneurysms
7.3.3.3 Arteriovenous Malformation
7.3.3.4 and Fistulas and Other target diseases
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Neurovascular Devices Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Aneurysm Coiling & Embolization Devices
7.4.2.2 Cerebral Balloon Angioplasty and Stenting Systems
7.4.2.3 Support Devices
7.4.2.4 Neurothrombectomy Devices
7.4.2.5 and Others
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Ischemic Strokes
7.4.3.2 Cerebral Aneurysms
7.4.3.3 Arteriovenous Malformation
7.4.3.4 and Fistulas and Other target diseases
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Neurovascular Devices Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Aneurysm Coiling & Embolization Devices
7.5.2.2 Cerebral Balloon Angioplasty and Stenting Systems
7.5.2.3 Support Devices
7.5.2.4 Neurothrombectomy Devices
7.5.2.5 and Others
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Ischemic Strokes
7.5.3.2 Cerebral Aneurysms
7.5.3.3 Arteriovenous Malformation
7.5.3.4 and Fistulas and Other target diseases
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Neurovascular Devices Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Aneurysm Coiling & Embolization Devices
7.6.2.2 Cerebral Balloon Angioplasty and Stenting Systems
7.6.2.3 Support Devices
7.6.2.4 Neurothrombectomy Devices
7.6.2.5 and Others
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Ischemic Strokes
7.6.3.2 Cerebral Aneurysms
7.6.3.3 Arteriovenous Malformation
7.6.3.4 and Fistulas and Other target diseases
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Neurovascular Devices Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Aneurysm Coiling & Embolization Devices
7.7.2.2 Cerebral Balloon Angioplasty and Stenting Systems
7.7.2.3 Support Devices
7.7.2.4 Neurothrombectomy Devices
7.7.2.5 and Others
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Ischemic Strokes
7.7.3.2 Cerebral Aneurysms
7.7.3.3 Arteriovenous Malformation
7.7.3.4 and Fistulas and Other target diseases
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Neurovascular Devices Scope:
|
Report Data
|
Neurovascular Devices Market
|
|
Neurovascular Devices Market Size in 2025
|
USD XX million
|
|
Neurovascular Devices CAGR 2025 - 2032
|
XX%
|
|
Neurovascular Devices Base Year
|
2024
|
|
Neurovascular Devices Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Medtronic, Johnson & Johnson, Stryker, Terumo Corporation, ASAHI INTECC CO., LTD..
|
|
Key Segments
|
By Type
Aneurysm Coiling & Embolization Devices
Cerebral Balloon Angioplasty and Stenting Systems
Support Devices
Neurothrombectomy Devices
and Others
By Applications
Ischemic Strokes
Cerebral Aneurysms
Arteriovenous Malformation
and Fistulas and Other target diseases
|
